Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Drug Interaction Study of SAR302503 in Patients With Solid Tumor [Phase 1]
Phase 1 drug interaction study of SAR302503 in patients with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-17Clinical Trial Update: Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports completion of a Phase 1/2 study evaluating LM-302 in combination with toripalimab in patients with advanc…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer [Phase 1]
A Phase 1 study of ALRN-6924, a dual MDM2/MDMX inhibitor, in pediatric cancers has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3) [Phase 1, Phase 2]
Clinical trial update for TAC-T cells targeting Claudin 18.2 in metastatic solid tumors (TACTIC-3), a Phase 1/2 study. The trial is currentl…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction [Phase 1]
A Phase 1 trial evaluating trametinib in patients with advanced solid tumors, including those with liver metastases, with or without hepatic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study [Phase 1]
Phase 1 pharmacokinetics study of sotrovimab as pre-exposure prophylaxis for COVID-19 in hematopoietic stem cell transplant recipients; the …
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Onalespib and CDKI AT7519 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 study evaluating Onalespib in combination with AT7519 in patients with advanced, metastatic, or unresectable solid tumors has been c…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: TCR-engineered T Cells in Solid Tumors: IMA202-101 [Phase 1]
This report updates the completion of a Phase 1 trial of IMA202-101, a TCR-engineered T cell therapy, tested in adults with solid tumors. It…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101) [Phase 1]
Phase 1 trial of IMA201-101 TCR-engineered T cells for solid tumors has been completed.
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 study of ORIN1001 in patients with advanced solid tumor and relapsed/refractory metastatic breast cancer has completed the trial…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Pilot Trial of Colchicine in Urothelial Cancer and Other Solid Tumors [Phase 1]
A Phase 1 pilot trial evaluating colchicine in urothelial cancer and other metastatic solid tumors has completed. The study, sponsored by Ic…
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 study assessing safety, tolerability, and preliminary efficacy of CJRB-101 in combination with pembrolizumab in selected advanced …
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid Tumors [Phase 1, Phase 2]
A Phase Ib/II study of BY101298, an oral DNA-PK inhibitor, in combination with radiotherapy for malignant solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors [Phase 1]
First-in-human study of the SHP2 inhibitor BBP-398 in advanced solid tumors has been terminated (Phase 1).
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Study of 23ME-01473 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
A clinical trial evaluating 23ME-01473 in advanced solid malignancies (Phase 1/2) conducted by 23andMe, Inc. has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors [Phase 1]
A Phase 1 trial of ABM-1310 in patients with BRAF V600-mutant advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: A Study of AB-106 in Chinese Healthy Adult Men Evaluated the Effects of Itraconazole and Rifampicin on AB-106 PK [Phase 1]
Phase 1 pharmacokinetic study evaluating the effects of itraconazole and rifampicin on AB-106 in Chinese healthy adult men to assess potenti…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin [Phase 1]
Phase 1 trial completed to evaluate the effect of AB-106 on the pharmacokinetics of digoxin in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy [Phase 1]
Phase 1 study evaluating the safety and tolerability of allogeneic blood-derived natural killer cells in cancers refractory to conventional …
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
This Phase 1 trial assessed the combination of onalespib with dabrafenib and trametinib in patients with BRAF-mutant melanoma or metastatic/…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer [Phase 1]
Phase 1 study of BRD/BET inhibitors BMS-986158 and BMS-986378 in pediatric cancers has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors [Phase 1]
Phase 1 pharmacokinetic drug-drug interaction study evaluating encorafenib and binimetinib on probe drugs in patients with BRAF V600-mutant …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer [Phase 1]
A first-in-human Phase 1 study of EOS100850 (Inupadenant) in adults with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC
This is a completed feasibility study at the Medical University of South Carolina evaluating circulating tumor DNA as a liquid biopsy in adu…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Injectable PEG-Irinotecan (JK-1201I) in Patients with Malignant Solid Tumor [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of the injectable PEGylated irinotecan JK-1201I in patients with m…